Mobilized Peripheral Blood Leukopaks

Key Biologics' (A Cellero Company) is conducting several research studies to evaluate the impact of repeated stem cell mobilization and product collections on normal subjects including assessment of the quality of collected products. Products collected under these protocols are provided to researchers and commercial entities.

Our mobilized mononuclear cells are sourced, processed, qualified, and delivered according to intended use and to your specifications. We offer multiple options for non-transfusable mobilized leukopak collections, including G-CSF mobilization, plerixafor mobilization, and G-CSF + plerixafor mobilization.

We are excited to announce a new level of cooperation with HemaCare facilitated by our recent acquisition by Charles River. Learn about some of the changes which will provide you with expanded access to high quality cellular materials.

show blocks helper
NOTICE: Product to be replaced. Learn More
Size: 10 to 15-liter blood volume processed
Price: Request a Quote
In Stock
NOTICE: Product to be replaced. Learn More
Size: 10 to 15-liter blood volume processed
Price: Request a Quote
In Stock
NOTICE: Product to be replaced. Learn More
Size: 10 to 15-liter blood volume processed
Price: Request a Quote
In Stock

Mobilized Peripheral Blood Leukopaks

Key Biologics’ (A Cellero Company) is conducting several research studies to evaluate the impact of repeated stem cell mobilization and product collections on normal subjects including assessment of the quality of collected products. Products collected under these protocols are provided to researchers and commercial entities.

Our mobilized mononuclear cells are sourced, processed, qualified, and delivered according to intended use and to your specifications. We offer multiple options for non-transfusable mobilized leukopak collections, including G-CSF mobilization, plerixafor mobilization, and G-CSF + plerixafor mobilization.

We are excited to announce a new level of cooperation with HemaCare facilitated by our recent acquisition by Charles River. Learn about some of the changes which will provide you with expanded access to high quality cellular materials.